Registre National des Cancers de l’Enfant

    Incidence rate (/million)    
Diagnostic groups and subgroups N Crude ASR Cumulative Sex ratio
I. Leukemias, myeloproliferative diseases, and myelodysplastic diseases 514 44 45.8 660 1.3
Ia. Lymphoid leukemias 410 35.1 36.7 526.7 1.3
Ib. Acute myeloid leukemias 72 6.2 6.4 93.7 1.2
Ic. Chronic myeloproliferative diseases 8 0.7 0.7 10.6 1.2
Id. Myelodysplastic syndromes and other myeloproliferative diseases 16 1.3 1.4 19.4 1.3
Ie. Unspecified and other specified leukemias 8 0.6 0.6 9.7 1.9
II. Lymphomas and reticuloendothelial neoplasms 184 15.7 14.7 235.6 1.9
IIa. Hodgkin lymphomas 86 7.3 6.6 109.2 1.4
IIb. Non-Hodgkin lymphomas (except Burkitt lymphomas) 56 4.7 4.5 70.6 1.8
IIc. Burkitt lymphomas 44 3.7 3.7 55.3 4.5
IId. Miscellaneous lymphoreticular neoplasms 0 0 0 0 -
IIe. Unspecified lymphomas 0 0 0 0 -
III. CNS and miscellaneous intracranial and intraspinal neoplasms 442 37.9 38.5 567.7 1.2
IIIa. Ependymomas and choroid plexus tumors 44 3.8 4.1 57.8 1.4
IIIb. Astrocytomas 168 14.4 14.7 215.6 1.1
IIIc. Intracranial and intraspinal embryonal tumors 82 7.0 7.4 106.0 1.6
IIId. Other gliomas 58 4.9 4.9 73.6 0.9
IIIe. Other specified intracranial and intraspinal neoplasms 86 7.3 7.0 108.8 1.4
IIIf. Unspecified intracranial and intraspinal neoplasms 6 0.4 0.5 7 1.2
IV. Neuroblastomas and other peripheral nervous cell tumors 142 12.1 13.9 184.1 1.2
IVa. Neuroblastomas and ganglioneuroblastomas 140 11.9 13.6 180.4 1.2
IVb. Other peripheral nervous cell tumors 2 0.2 0.2 3.7 0.8
V. Retinoblastomas 48 4.0 4.7 61.1 1.1
VI. Renal tumors 98 8.3 9.2 125.1 0.9
VIa. Nephroblastomas and other nonepithelial renal tumors 94 8.1 9.0 122.1 0.9
VIb. Renal carcinomas 2 0.2 0.2 4.0 0.4
VIc. Unspecified malignant renal tumors 0 0 0 0 -
VII. Hepatic tumors 20 1.6 1.8 24.8 1.3
VIIa. Hepatoblastomas 16 1.4 1.6 20.8 1.4
VIIb. Hepatic carcinomas 2 0.2 0.2 3.4 1.3
VIIc. Unspecified malignant hepatic tumors <1 0 0 0.3 0.0
VIII. Malignant bone tumors 82 7.1 6.5 106 1
VIIIa. Osteosarcomas 40 3.4 3.0 50.8 0.8
VIIIb. Chondrosarcomas 2 0.2 0.2 2.8 1.0
VIIIc. Ewing tumors and related bone sarcomas 38 3.2 3.0 48.6 1.1
VIIId. Other specified malignant bone tumors 2 0.2 0.2 2.9 0.8
VIIIe. Unspecified malignant bone tumors <1 0.1 0.1 1.4 3.0
IX. Soft tissue and other extraosseous sarcomas 112 9.5 9.8 143.6 1.2
IXa. Rhabdomyosarcomas 62 5.2 5.5 78.2 1.3
IXb. Fibrosarcomas, peripheral nerve sheath tumors, and other fibrous neoplasms 8 0.7 0.7 10.5 1.4
IXc. Kaposi sarcomas 0 0 0 0 -
IXd. Other specified soft tissue sarcomas 34 2.9 2.9 44.0 1.1
IXe. Unspecified soft tissue sarcomas 8 0.7 0.7 10.9 0.9
X. Germ-cell tumors, trophoblastic tumors, and neoplasms of gonads 60 5.1 5.2 77.6 0.9
Xa. Intracranial and intraspinal germ cell tumors 26 2.1 2.1 32.2 2.3
Xb. Malignant extracranial and extragonadal germ cell tumors 16 1.4 1.6 20.9 0.6
Xc. Malignant gonadal germ cell tumors 18 1.5 1.4 22.5 0.4
Xd. Gonadal carcinomas <1 0.1 0.1 1.0 0
Xe. Other and unspecified malignant gonadal tumors 2 0.1 0.1 2.0 0
XI. Other malignant epithelial neoplasms and malignant melanomas 64 5.5 5.1 82.5 0.7
XIa. Adrenocortical carcinomas 6 0.5 0.5 7.1 1.1
XIb. Thyroid carcinomas 22 1.9 1.7 28.1 0.5
XIc. Nasopharyngeal carcinomas 6 0.4 0.4 6.5 2.6
XId. Malignant melanomas 12 1.0 0.9 14.5 1.2
XIe. Skin carcinomas 2 0.2 0.2 3.4 0.4
XIf. Other and unspecified carcinomas 18 1.6 1.4 23.4 0.5
XII. Other and unspecified malignant neoplasms 4 0.4 0.4 6.0 0.8
XIIa. Other specified malignant tumors 4 0.4 0.4 5.5 0.7
XIIb. Other unspecified malignant tumors <1 0 0 0.5 -
All cancers (excluding LCH) 1770 151.3 155.5 2270.9 1.2
Langherhans cell histiocytosis 8 0.6 0.7 9.4 0.7
All cancers (including LCH) 1778 151.9 156.2 2280.3 1.2

ASR: age standardised incidence rate

Annual number of cases (N), crude, age standardised and cumulative incidence rate of childhood cancer, and sex ratio (mainland France, 2010-2014).

Villejuif

INSERM
UMRS1153 Equipe 7
Bâtiment 15/16
16 avenue Paul Vaillant Couturier
94807 Villejuif Cedex

+33 (0)1 45 59 50 37
rnhe@inserm.fr

Nancy

Faculté de Médecine
BP 20199
9 avenue de la Forêt de Haye
54505 Vandoeuvre les Nancy Cedex

+33 (0)3 72 74 63 26
rntse@inserm.fr